Syntegon is set to present its comprehensive portfolio for the development and production of oral solid dosage (OSD) forms.
“We are currently seeing two trends that offer pharmaceutical companies different advantages: on the one hand, production in ever larger batches and, on the other hand, continuous manufacturing,” says Fritz-Martin Scholz, Product Manager at Syntegon. “We are continuing to develop our existing portfolio in both directions and can therefore identify and implement the best solution for our customers’ applications.” An exemplary OSD production line and further exhibits give trade show visitors the opportunity to see this wide range of possibilities.
